Critical

Haemolytic uraemic syndrome (HUS)

Thrombotic microangiopathy · Renal / Electrolyte
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

A thrombotic microangiopathy defined by the triad of microangiopathic haemolytic anaemia, thrombocytopenia and acute kidney injury. Typical (STEC-HUS) follows Shiga-toxin E. coli O157 / Shigella — usually a child after bloody diarrhoea. Atypical HUS (aHUS) is complement-mediated. Renal injury predominates (vs neurological in TTP).

Figures & algorithms

Schistocytes (MAHA)
Schistocytes (MAHA)

Red flags

  • Anuria / severe AKI, hyperkalaemia
  • Fluid overload / pulmonary oedema
  • Neurological features (suggests TTP or severe disease)
  • Severe hypertension

Assessment

Differential diagnosis

  • TTP (neuro-predominant, ADAMTS13 <10%)
  • DIC (abnormal coagulation)
  • Sepsis
  • Malignant hypertension
  • HELLP / pregnancy TMA
  • Scleroderma renal crisis

Investigations

  • FBC + film — schistocytes + thrombocytopenia
  • U&E / creatinine — acute kidney injury
  • LDH up, haptoglobin down, bilirubin up, reticulocytes up; DAT negative
  • Coagulation NORMAL
  • Stool culture + Shiga-toxin PCR (STEC)
  • ADAMTS13 (to exclude TTP); complement studies if atypical
  • Urinalysis; group & save

Management

  • STEC-HUS is mainly SUPPORTIVE — careful fluid & electrolyte management, treat AKI (dialysis if needed)
  • Transfuse red cells for symptomatic anaemia
  • AVOID antibiotics and antimotility agents in suspected STEC (may worsen HUS)
  • AVOID platelet transfusion unless life-threatening bleeding
  • If TTP not yet excluded or neuro features — start plasma exchange
  • Atypical HUS (no diarrhoea / recurrent) — urgent complement inhibitor (eculizumab) after meningococcal cover
  • Nephrology + critical care

Drugs & doses

Supportive: IV fluids, electrolyte correction
Red cell transfusion (symptomatic anaemia)
Eculizumab (atypical HUS)
Dialysis (renal support)
Empirical antibiotics per BNF — see the in-app Antibiotic Dosing tool

Disposition

Nephrology + critical care; dialysis access.

Complications & pitfalls

  • AKI requiring dialysis; chronic kidney disease
  • Hypertension
  • Neurological involvement
  • Death

Exam pearls

  • Child with bloody diarrhoea then falling platelets + AKI = STEC-HUS
  • Do NOT give antibiotics or loperamide in suspected STEC
  • Renal failure predominates in HUS; neurology in TTP
  • No diarrhoeal prodrome or recurrent disease = think atypical HUS (eculizumab)

STEC-HUS is largely supportive (dialysis as needed); atypical HUS needs urgent complement inhibition. If neuro features or TTP not excluded, start plasma exchange. Antibiotic doses per BNF (current edition); confirm choice in the in-app Antibiotic Dosing tool.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.